Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics.
Dzau
V J
VJ
Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, USA.
Mann
M J
MJ
Ehsan
A
A
Griese
D P
DP
D001672:Biocompatible Materials / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000601:surgery / Q000628:therapy*; D016228:Endothelial Growth Factors / Q000235:genetics / Q000627:therapeutic use; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods / Q000639:trends*; D005822:Genetic Vectors / Q000627:therapeutic use; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D006965:Hyperplasia / Q000517:prevention & control; D007165:Immunosuppression Therapy / Q000379:methods; D008222:Lymphokines / Q000235:genetics / Q000627:therapeutic use; D009389:Neovascularization, Pathologic / Q000628:therapy; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D010957:Plasmids / Q000627:therapeutic use; D014162:Transfection; D019076:Transgenes; D017211:Treatment Failure; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014680:Veins / Q000601:surgery / Q000637:transplantation
D001672:Biocompatible Materials; D016228:Endothelial Growth Factors; D008222:Lymphokines; D016376:Oligonucleotides, Antisense; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors